Faculty

Leland S. Hu, M.D.

Clinical Studies

20203027: SAGE MRI: Perfusion MRI for Therapy Response Assessment in Brain Cancer (SAGE) Scottsdale/Phoenix, Ariz.
The purpose of this study is to improve patient care by optimizing and measuring magnetic resonance imaging methods for the early detection of brain cancer response to therapy.
Image-based Mapping of Brain Tumors Scottsdale/Phoenix, Ariz.
The purpose of this study is to combine MRI images with histologic and genetic analysis of cancer (from blood and tissue samples) to improve the overall accuracy of diagnosis and effectiveness of cancer treatment.
Mapping of electrical properties in the brain Scottsdale/Phoenix, Ariz.
The purpose of this study is to Correlate image-based electrophysiologic models/measurements with loco-regional benchmarks including sequencing and functional data from and structural tissue assays (from available biopsies), and correlative clinical features (e.g., histology, outcomes, treatment, etc).

EAF151, Change in Relative Cerebral Blood Volume as a Biomarker for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville, Fla.
This phase II trial studies how well dynamic susceptibility contrast-enhanced magnetic resonance imaging (DSC-MRI) works in measuring relative cerebral blood volume (rCBV) for early response to bevacizumab in patients with glioblastoma that has come back. DSC-MRI may help evaluate changes in the blood vessels within the cancer to determine a patient?s response to treatment.
Image-based Mapping of Brain Tumors Rochester, Minn.
The purpose of this study is to combine MRI images with histologic and genetic analysis of cancer (from blood and tissue samples) to improve the overall accuracy of diagnosis and effectiveness of cancer treatment.